TABLETTEN MIT ELTROMBOPAG OLAMIN

Patent europeic · EP4400104 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4400104
Numer da la dumonda
EP24178734
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
01-08-2007
Publitgà
17-07-2024
Concedì
22-04-2026
La protecziun finescha il pli tard
31-07-2027
Proxima taxa annuala scadenta
31-08-2027
Classas IPC
A61K 9/14 (2006.01)
A61K 9/54 (2006.01)
A61K 47/34 (2017.01)
A61P 7/06 (2006.01)
A61K 31/4152 (2006.01)
A61K 9/20 (2006.01)
A61K 47/26 (2006.01)
Prioritad
US 915761 P 03.05.2007
US 947731 P 03.07.2007
Derivà da
EP23166857
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-09-2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. 22-04-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 22.04.2026

Partidas

Possessur

Novartis Pharma AG

Lichtstrasse 35, 4056 Basel

Inventur

KAPSI, Shivakumar, G.

King Of Prussia, 19406, US

MULLER, Francis, X.

King Of Prussia, 19406, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.